학술논문

Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional study
Document Type
Article
Source
In: Neuro-Oncology. (Neuro-Oncology, 1 July 2022, 24(7):1166-1175)
Subject
Language
English
ISSN
15235866
15228517